Biotop-report 2014

56

BioTOPics 47 | May 2014 

BioTOP-Report

 Addresses

Biotech Companies

nanoPET Pharma GmbH

As a technology and service provider to the biopharmaceutical industry nanoPET fo-

cuses on the R&D, production as well as marketing of  innovative drug substances for 

diagnostic imaging based on novel nanoparticular materials. nanoPET offers consulting 

and contract research services, preclinical contrast agents (MRT, CT, US, NIR, PET) as 

catalog items and pursues the preclinical development of  its patented core technology 

of  inorganic nanoparticle PET tracers.

nanopet-pharma.com

NovaBiotec

®

 Dr. Fechter GmbH

Microbiological and chemical investigations, in particular of  soil, water and air samples, 

planning / inspection of  sanitation, in particular analytics and sanitation support for 

mould and dry rot, incl. education in this field. Delivery of  production auxilliaries and 

support for biogas plants with biological treatment processes incl. application, insula-

tion and preservation of  enzymes. Research, development and marketing of  test kits 

for breweries and malthouses.

novabiotec.de

NOXXON Pharma AG

NOXXON Pharma is a biopharmaceutical company pioneering the development of  

a new class of  proprietary therapeutics called Spiegelmers. Spiegelmers are the 

chemically synthesized, non-immunogenic alternative to antibodies. NOXXON has a 

diversified portfolio of  clinical stage Spiegelmer therapeutics: Spiegelmer

®

 NOX-E36, 

Spiegelmer

®

 NOX-A12, Spiegelmer

®

 NOX-H94. The Spiegelmer platform provides the 

Company with powerful and unique discovery capabilities, which have generated a 

number of  additional leads under preclinical investigation. Located in Berlin, Germany, 

NOXXON is a well financed mature biotech company with a strong syndicate of  inter-

national investors, approx. 60 employees and a highly experienced management team.

noxxon.com

OakLabs GmbH

OakLabs provides the most flexible products and services for large scale custom SNP 

genotyping on the market. OakLabs offers several formats for analysing a variable num-

ber of  SNPs in any sequenced organism. 

oak-labs.com

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH is a clinical development company focusing on diagnos-

tic radiopharmaceuticals. 

octreopharmsciences.com

Omeicos Therapeutics GmbH

OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing 

a new Mode of  Action for the treatment and prevention of  atrial fibrillation. OMEICOS' 

novel therapeutic strategy is based upon the discovery of  natural metabolites of  ome-

ga-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other an-

ti-arrhythmic drugs, OMEICOS' substances activate an endogenous cardio-protective 

signaling pathway that not only stabilizes the heart rhythm but shall provide curative 

effects to the diseased organ by preventing its electrical and structural remodeling.

omeicos.com

OpTricon 

Entwicklungsgesellschaft für 

optische Technologien mbH

OpTricon develops and produces mobile readers for quantitative analyzes of  Immuno-

assays for Point-of-Care-diagnostics, especially Lateral Flow Assays (LFA). Additional 

business segments are components and Systems for signal transmission and sensors 

for lbioanalytics. opTricon develops the devices in partnership with the customers 

and works as OEM-suppliers and is certified by TÜV Rheinland according EN ISO 

13485:2003+AC: 2007 and EN ISO 9001:2008.

optricon.de

ORGANOBALANCE GmbH

ORGANOBALANCE is a company specializing in microbial strain development and 

screening. As a R&D contractor ORGANOBALANCE develops new biological products 

in the areas of  nutrition, personal care and health care. The company draws on its own 

collection of  microbial strains suitable for food applications and its OASSYS

®

 bioassay 

systems. In the field of  “metabolic engineering” ORGANOBALANCE exploits Saccha-

romyces cerevisiae yeast for synthesis of  substances for the industrial and pharma-

ceutical industry.

organobalance.com

ORGANOBALANCE Medical AG

ORGANOBALANCE Medical AG funds and promotes the research and development 

of  novel therapies based on specific probiotic cultures, aiming to develop active sub-

stances and mechanisms for innovative medicinal products and medical devices, as 

well as offer new therapeutic concepts for hitherto inadequately treatable indications.

organobalancemedical.com

ovalehn GmbH

Production and application of  specific recipes -containing IgY for diagnostics and oral, 

passive immune therapy.

ovalehn.de

Pentracor GmbH

In the case of  cardiac infarction, C-reactive protein (CRP) results in an increase of  the 

primary damage. Based on a new prototype, the company Pentracor GmbH aims to 

develop an adsorber for therapeutic reduction of  CRP, lead it to approval, establish its 

certified production and market the product after clinical validation.

pentracor.com

Peptides&elephants GmbH

Custom synthesis of  peptides and peptide libraries Development parallel Synthesis 

technologies Distributor of  Peptide Synthesis Automation.

peptides.de

PharmaSol GmbH

Modification of  ingredients or introduction of  new metabolic pathways in plants with 

gene-technology methods.

pharmasol-berlin.de

PlasmaChem GmbH

PlasmaChem GmbH is an innovative R&D and manufacturing company specializing in 

nanomaterials, plasma- and ultra-thin film technologies. The company manufactures 

nano-coated medical implants (stents), nanomaterials, additives for metal plating (ap-

plied e.g. by Siemens AG), new additives to engine oils on the base of  nanodiamonds 

and other industrial nanoproducts.

plasmachem.com

---